logo

Turning Point Therapeutics (TPTX)



Trade TPTX now with
  Date
  Headline
8/24/2020 8:45:32 AM Turning Point Therapeutics Granted Fast-Track Designation For Repotrectinib
8/19/2020 7:10:55 AM Turning Point Therapeutics Reports Early Interim Data From Registrational Phase 2 Trident-1 Study Of Repotrectinib
7/7/2020 7:40:34 AM Turning Point Therapeutics And Zai Lab Announce License Agreement For Repotrectinib In Greater China
5/18/2020 7:07:29 AM Turning Point Therapeutics Commences Public Offering For $250 Mln Of Shares
9/30/2019 8:39:13 AM Turning Point Therapeutics Announces FDA Clearance Of IND For TPX-0046
7/31/2019 8:46:34 AM Turning Point Therapeutics Begins Phase 1 Clinical Study Of Tpx-0022
6/20/2019 9:08:06 AM Turning Point Begins Phase 2 Registrational Portion Of TRIDENT-1 Study
4/13/2019 1:15:14 PM Biotech IPOs For The Week Ahead